Search

Barbara A Sosnowski

from Coronado, CA
Age ~65
Get Report
Also known as:
Barbara K Sosnowski, Barbara Ann Kirschner, Barbara A Kirschner, Barbara A Sosnwski, Barba Sosnowski, Barb Sosnowski, Sosnowski Barba, Barbara I
Phone and address:
1013 Adella Ave, San Diego, CA 92118
Related to:
Hector Lopez Martinez, 41Jaime Barba, 48Nicholas A CoYolanda Barba, 39Alejandro Barba, 46
Connected to:
Alyce J Sosnowski, 78Edward A Sosnowski, 53Irene Sosnowski, 47Mark C Sosnowski, 59Don C Sosnowy, 52Cruz R Sosof, 65Leon Sosower, 100Asdrubal G Sossa, 79Jason D Sossaman, 46Lucy E Sossaman, 43

Barbara Sosnowski Phones & Addresses

  • 1013 Adella Ave, Coronado, CA 92118
  • San Diego, CA
  • Buena Vista, CO
  • Breckenridge, CO
  • Boston, MA
  • Ann Arbor, MI

Work

Position: Service Occupations

Education

Degree: Associate degree or higher

Emails

b***[email protected]

Resumes

Resumes

Barbara Sosnowski Photo 1

Chief Operations Officer

View page
Location:
1013 Adella Ave, Coronado, CA 92118
Industry:
Biotechnology
Work:
Pfizer
Vice President and Global Head, Emerging Science and Innovation Leads, Wwrdm
Pfizer
Vice President and Erdi Head, Cambridge Research Units; Global Head, Wrd External Partnerships
Pfizer Apr 2013 - May 2016
Vice President External R and D Innovation
Pfizer Apr 1, 2010 - Apr 2013
Executive Director, Head of Tissue Homeostasis and Inflammation and Remodelig, External R and D Innovation
Tissue Repair Company Aug 2006 - Apr 2010
Chief Operating Officer
Education:
The Johns Hopkins University 1981 - 1987
Doctorates, Doctor of Philosophy, Biology Academy of Our Lady of Peace
University of California, Berkeley
The Johns Hopkins University
Skills:
Pharmaceutical Industry
Life Sciences
Biotechnology
Research and Development
Drug Discovery
Drug Development
Biopharmaceuticals
Oncology
Technology Transfer
Clinical Development
Interests:
Collecting Antiques
Exercise
Home Improvement
Reading
Sports
The Arts
Home Decoration
Cooking
Gardening
Cruises
Outdoors
Electronics
Music
Movies
Collecting
Kids
Travel
Boating
Traveling
International Traavel
Languages:
English
Barbara Sosnowski Photo 2

Barbara Sosnowski

View page
Barbara Sosnowski Photo 3

Barbara Sosnowski

View page
Barbara Sosnowski Photo 4

Coo At Tissue Repair Company

View page
Position:
COO at Tissue Repair Company
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
Tissue Repair Company
COO

Business Records

Name / Title
Company / Classification
Phones & Addresses
Barbara Sosnowski
President, Vice President Of Research And Development
Selective Genetics, Inc.
Surgical and Medical Instruments
11545 Sorrento Vly Rd #310, San Diego, CA 92121
(858) 793-6641
Barbara K. Sosnowski
Chief Operating Officer
Tissue Repair Company
Noncommercial Research Organization
6740 Top Gun St, San Diego, CA 92121
(858) 793-6641

Publications

Us Patents

Compositions Containing Nucleic Acids And Ligands For Therapeutic Treatment

View page
US Patent:
6503886, Jan 7, 2003
Filed:
Nov 24, 1999
Appl. No.:
09/449249
Inventors:
J. Andrew Baird - San Diego CA
Lois Ann Chandler - Encinitas CA
Barbara A. Sosnowski - Coronado CA
Assignee:
Selective Genetics, Inc. - San Diego CA
International Classification:
A61K 3170
US Classification:
514 44, 4353201, 435325, 435455, 424 932
Abstract:
Preparations of conjugates of a receptor-binding internalized ligand and a cytocide-encoding agent and compositions containing such preparations are provided. The conjugates contain a polypeptide that is reactive with an FGF receptor, such as bFGF, or another heparin-binding growth factor, cytokine, or growth factor coupled to a nucleic acid binding domain. One or more linkers may be used in the conjugation. The linker is selected to increase the specificity, toxicity, solubility, serum stability, or intracellular availability, and promote nucleic acid condensation of the targeted moiety. The conjugates are complexed with a cytocide-encoding agent, such as DNA encoding saporin. Conjugates of a receptor-binding internalized ligand to a nucleic acid molecule are also provided.

Viral Vectors With Modified Tropism

View page
US Patent:
6613563, Sep 2, 2003
Filed:
Mar 13, 1998
Appl. No.:
09/039060
Inventors:
Barbara A. Sosnowski - Coronado CA
Andrew Baird - San Diego CA
Glenn F. Pierce - Rancho Santa Fe CA
David T. Curiel - Birmingham AL
Joanne T. Douglas - Huntsville AL
Buck E. Rogers - Birmingham AL
Assignee:
Selective Gentics, Inc. - San Diego CA
UAB Research Foundation - Birmingham AL
International Classification:
C12N 1500
US Classification:
4353201, 536 231, 536 235, 4241301, 4241471, 530350
Abstract:
The present invention relates to gene therapy. In particular, therapeutic agents, therapeutic gene products, and compositions are disclosed. Various systems and methods useful in targeting and delivering non-native nucleotide sequences to specific cells are disclosed, wherein virus-antibody-ligand conjugates are used to facilitate targeting and delivery.

Compositions Containing Nucleic Acids And Ligands For Therapeutic Treatment

View page
US Patent:
7138381, Nov 21, 2006
Filed:
Jul 2, 2002
Appl. No.:
10/189360
Inventors:
J. Andrew Baird - London, GB
Lois Ann Chandler - Encinitas CA, US
Barbara A. Sosnowski - Coronado CA, US
Assignee:
Prizm Pharmaceuticals, Inc. - San Diego CA
International Classification:
A01N 31/70
C12N 15/00
C12N 5/00
A61K 48/00
US Classification:
514 44, 424 932, 4353201, 435325, 435455
Abstract:
Preparations of conjugates of a receptor-binding internalized ligand and a cytocide-encoding agent and compositions containing such preparations are provided. The conjugates contain a polypeptide that is reactive with an FGF receptor, such as bFGF, or another heparin-binding growth factor, cytokine, or growth factor coupled to a nucleic acid binding domain. One or more linkers may be used in the conjugation. The linker is selected to increase the specificity, toxicity, solubility, serum stability, or intracellular availability, and promote nucleic acid condensation of the targeted moiety. The conjugates are complexed with a cytocide-encoding agent, such as DNA encoding saporin. Conjugates of a receptor-binding internalized ligand to a nucleic acid molecule are also provided.

Traversal Of Nucleic Acid Molecules Through A Fluid Space And Expression In Repair Cells

View page
US Patent:
7534774, May 19, 2009
Filed:
Oct 2, 2002
Appl. No.:
10/264284
Inventors:
Barbara A. Sosnowski - Coronado CA, US
Glenn Pierce - Rancho Santa Fe CA, US
Assignee:
Tissue Repair Company - San Diego CA
International Classification:
A61K 48/00
A01N 63/00
US Classification:
514 44, 424 931
Abstract:
Disclosed are methods for use in transferring nucleic acids into cells at a wound site associated with a fluid space. These gene transfer protocols are suitable for use in transferring various nucleic acids into cartilage, cardiac muscle, and other tissues, and have many uses including treating diseases such as arthritis and ischemic heart disease, and promoting wound healing. The invention further disclosed pharmaceutical compositions that may be used in the practice of the invention to transfer the nucleic acid of interest. Such compositions include any multi-partitioned biocompatible matrix in combination with multiple nucleic acids of interest.

Methods For Halting Unwanted Cell Growth, Such As Using Ligand-Directed Nucleic Acid Delivery Vehicles

View page
US Patent:
20030040496, Feb 27, 2003
Filed:
May 17, 2001
Appl. No.:
09/861257
Inventors:
Lois Chandler - Encinitas CA, US
Barbara Sosnowski - Coronado CA, US
Andrew Baird - San Diego CA, US
Glenn Pierce - Rancho Sante Fe CA, US
International Classification:
A61K048/00
A61K039/395
US Classification:
514/044000, 424/143100, 514/008000
Abstract:
Methods of treating tumors with preparations of conjugates of a receptor-binding internalized ligand and a cytocide-encoding agent are provided. The conjugates contain a polypeptide that is reactive with an FGF receptor, such as FGF2, or other ligand coupled to a nucleic acid binding domain. One or more linkers may be used in the conjugation. The linker is selected to increase the specificity, toxicity, solubility, serum stability, or intracellular availability, and promote nucleic acid condensation of the targeted moiety. The conjugates are complexed with a cytocide-encoding agent, such as DNA encoding saporin or a prodrug-encoding agent. Conjugates of a receptor-binding internalized ligand to a nucleic acid molecule are also provided.

Viral Vectors With Modified Tropism

View page
US Patent:
20040029280, Feb 12, 2004
Filed:
Apr 3, 2003
Appl. No.:
10/408849
Inventors:
Barbara Sosnowski - Coronado CA, US
Andrew Baird - San Diego CA, US
Glenn Pierce - Rancho Santa Fe CA, US
David Curiel - Birmingham AL, US
Joanne Douglas - Huntsville AL, US
Buck Rogers - Birmingham AL, US
International Classification:
C12N015/861
US Classification:
435/456000
Abstract:
The present invention relates to gene therapy. In particular, therapeutic agents, therapeutic gene products, and compositions are disclosed. Various systems and methods useful in targeting and delivering non-native nucleotide sequences to specific cells are disclosed, wherein virus-antibody-ligand conjugates are used to facilitate targeting and delivery.

Traversal Of Nucleic Acid Molecules Through A Fluid Space And Expression In Repair Cells

View page
US Patent:
20100086598, Apr 8, 2010
Filed:
May 11, 2009
Appl. No.:
12/463893
Inventors:
Barbara A. Sosnowski - Coronado CA, US
Glenn Pierce - Rancho Santa Fe CA, US
Assignee:
TISSUE REPAIR COMPANY - San Diego CA
International Classification:
A61K 9/14
A61K 31/7088
A61P 19/02
US Classification:
424486, 424484, 514 44 R
Abstract:
Disclosed are methods for use in transferring nucleic acids into cells at a wound site associated with a fluid space. These gene transfer protocols are suitable for use in transferring various nucleic acids into cartilage, cardiac muscle, and other tissues, and have many uses including treating diseases such as arthritis and ischemic heart disease, and promoting wound healing. The invention further disclosed pharmaceutical compositions that may be used in the practice of the invention to transfer the nucleic acid of interest. Such compositions include any multi-partitioned biocompatible matrix in combination with multiple nucleic acids of interest.

Traversal Of Nucleic Acid Molecules Through A Fluid Space And Expression In Repair Cells

View page
US Patent:
20130190391, Jul 25, 2013
Filed:
Aug 3, 2012
Appl. No.:
13/566389
Inventors:
Barbara A. Sosnowski - Coronado CA, US
Glenn Pierce - Rancho Santa Fe CA, US
Assignee:
CARDIUM BIOLOGICS, INC. - San Diego CA
International Classification:
A61K 31/7088
US Classification:
514 44 R
Abstract:
Disclosed are methods for use in transferring nucleic acids into cells at a wound site associated with a fluid space. These gene transfer protocols are suitable for use in transferring various nucleic acids into cartilage, cardiac muscle, and other tissues, and have many uses including treating diseases such as arthritis and ischemic heart disease, and promoting wound healing. The invention further disclosed pharmaceutical compositions that may be used in the practice of the invention to transfer the nucleic acid of interest. Such compositions include any multi-partitioned biocompatible matrix in combination with multiple nucleic acids of interest.
Control profile
Barbara A Sosnowski from Coronado, CA, age ~65 Get Report